ABOUT
Staff
Our Members
Sponsors
Board of Directors
Contact Us
Issue Areas
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
Personalized Health
FDA Regulations
Resources
Member Resources
Meetings & Events
Newsroom
Letters & Comments
Job Bank
Education
PCOR Training
Health Care Quality
Health Economics 101
Webinars
Blog
Membership
Standards of Excellence
Join Us
Toggle navigation
letters & comments
Medicare and State Healthcare Programs: Fraud and Abuse; Revisions To Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements
December 31, 2019
Read More
Letter to CMS on Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations
December 31, 2019
Read More
NHC Comments on Patient-Focused Drug Development: Methods to Identify What Is Important to Patients; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders
December 18, 2019
Read More
NHC Comments on Congressional Efforts to Address Drug Pricing
December 17, 2019
Read More
Letter to Representatives DeGette & Upton on the “Cures 2.0” Initiative
December 16, 2019
Read More
NHC Comments on Proposed Changes to ICER’s 2020 Framework
October 18, 2019
Read More
NHC Comments on CY 2020 Revisions to Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies
September 27, 2019
Read More
NHC Comments on Proposed Changes to the Medicare Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System
September 27, 2019
Read More
NHC Comments on Value Assessment Methods for Single or Short-Term Transformative Therapies (SSTs)
September 6, 2019
Read More
« Previous
1
2
3
4
Next »
